Rehermann Barbara
Liver Diseases Section, NIDDK, National Institutes of Health, HHS, Bethesda, Maryland 20892, USA.
Semin Liver Dis. 2003 Feb;23(1):21-38. doi: 10.1055/s-2003-37586.
Hepatitis B virus infection is one of the most frequent causes of chronic liver disease worldwide. Even though a preventive vaccine is available, the search for a cure for chronically infected patients remains a high priority to reduce the morbidity and mortality from liver cirrhosis and hepatocellular carcinoma. This review summarizes the immune response in acute, self-limited and chronic hepatitis B; its differential effects on viral replication and liver injury; and prospects for immunotherapy.
乙肝病毒感染是全球慢性肝病最常见的病因之一。尽管已有预防性疫苗,但寻求治愈慢性感染患者的方法仍是当务之急,以降低肝硬化和肝细胞癌的发病率和死亡率。这篇综述总结了急性、自限性和慢性乙肝中的免疫反应;其对病毒复制和肝损伤的不同影响;以及免疫治疗的前景。